profit from every $100 of sales.
$0$100
Core Laboratories
$9.11+1.11% today
-39.5% in 1 year
1-year low $8.841-year high $19.67
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $14.07 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Core Laboratories sold, what it kept, and what it did with the cash.
Sales went from $490 million in 2022 to $527 million in 2025, with $29.7 million of profit last year.
SalesProfit
Core Laboratories handed back 64% of the cash it generated last year.
Buybacks $12M
Free cash flow 2025$22M
Bought back its own shares$12M
Paid as dividends$2M
Cash vs. debt$23M vs. $164M
Core Laboratories vs. similar companies
Core Laboratories grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Core Laboratories | 14.1× · Cheap | ||
 SLB | 22.6× · Fair price | ||
 Baker Hughes | 19.0× · Fair price | ||
 Tenaris | 16.0× · Fair price | ||
 Halliburton | 21.8× · Fair price |
AI analysis
An AI analyst reads Core Laboratories's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 490 | 510 | 524 | 527 | |
| 79 | 94 | 88 | 94 | |
| 41 | 56 | 50 | 50 | |
| 59 | 70 | 74 | 71 | |
| 19 | 37 | 31 | 30 | |
| 0.42 | 0.86 | 0.66 | 0.68 | |
| 16.1% | 18.4% | 16.9% | 17.9% | |
| 8.4% | 11.0% | 9.5% | 9.6% | |
| 4.0% | 7.2% | 6.0% | 5.6% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 578 | 586 | 585 | 584 |
| Cash | 15 | 15 | 19 | 23 |
| Total debt | 222 | 215 | 180 | 164 |
| Total liabilities | 389 | 357 | 333 | 312 |
| 184 | 225 | 247 | 266 | |
| 47 | 48 | 48 | 47 | |
| 8.1% | 9.8% | 10.8% | 10.4% | |
| 10.6% | 16.3% | 12.7% | 11.2% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 25 | 25 | 56 | 37 | |
| 10 | 11 | 13 | 15 | |
| 15 | 14 | 43 | 22 | |
| Dividends paid | 2 | 2 | 2 | 2 |
| 4 | 2 | 5 | 12 | |
| 8 | 14 | 4 | 7 |
Valuation
- 14.1×
- 14.8×
- 0.80
- 2.2×
- 0.8×
- 18.7×
- 7.9×
- 5.3%
- 7.1%
- 0.3%
Profitability
- 17.9%
- 9.6%
- 5.6%
- 13.8%
- 7.7%
- 6.3%
- 10.7%
- 4.9%
- 11.2%
- –
Growth
- +2.4%
- +17.7%
- −47.9%
- −32.2%
- +0.3%
Financial health
- 0.3×
- 0.15
- 7.0%
- 5.0×
- 2.05
- 1.50
- 0.89
How it ranks in Energy
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 49%of 467
Bottom 40%of 466
Top 37%of 387
Top 46%of 461
Top 49%of 460
What analysts expect
- Average price target
- $25.00
- Range
- $17.00 – $32.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 29, 2026 | 0.06 | 0.06 | +0.0% |
| Feb 4, 2026 | 0.21 | 0.19 | +9.8% |
| Oct 22, 2025 | 0.22 | 0.19 | +15.8% |
| Jul 23, 2025 | 0.19 | 0.18 | +5.6% |
| Apr 23, 2025 | 0.14 | 0.15 | −6.7% |
| Jan 29, 2025 | 0.22 | 0.23 | −4.3% |
| Oct 23, 2024 | 0.25 | 0.23 | +8.7% |
| Jul 24, 2024 | 0.22 | 0.21 | +4.8% |
0.3%of the share price, paid each year
On $1,000 invested$3a year at today's yield, before tax
−32.2%2020 to 2025
Raised–not every year
Paid per share, each year
$2.20 in 2015 → $0.04 in 2025
How safe it looks
6.3% of its profit
Room to growStretchedMore than it earns: 8.4%
News
Core Critical Metals launches $500K flow-through private placementSeeking Alpha · Nov 13, 2026iShares Core S&P 500 (IVV) Sells $17.8 Million More Apple on MondayYahoo Finance · Nov 11, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
54No pass
Benjamin Graham
69Pass
Philip Fisher
50No pass
Peter Lynch
64Pass
Joel Greenblatt
44No pass
Charlie Munger
42No pass
Terry Smith
35No pass
Questions about Core Laboratories
Is Core Laboratories a good stock to buy?
A business with weak numbers, and the price looks low. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Core Laboratories AI analysis
What does Core Laboratories do?
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. It is in Oil & Gas Equipment & Services.
Does Core Laboratories pay a dividend?
Yes. At today's price the dividend is 0.3% a year, about 6% of its yearly profit. In 2025 it paid out $1.87 million in dividends.
Is Core Laboratories stock halal?
No. Core Laboratories does not pass our halal screen: its debt is 39% of its market value, at or above the 33% limit. How we check
How has Core Laboratories stock done over the past year?
Down 39.5% over the past twelve months, to $9.11. It traded between $8.84 and $19.67 and is 53.7% below its high.
Who are Core Laboratories's competitors?
The largest listed companies in the same industry are SLB, Baker Hughes, Tenaris and Halliburton. The peers table on this page compares their profit, growth and price with Core Laboratories's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.